Brian Lee Ferris M.D. Curriculum Vitae Lake Washington Vascular, PLLC 1135 116 th Ave NE Suite 305 Bellevue, Washington 98004 And 12333 NE 130 th Lane Suite 425 Kirkland, Washington 98034 425-453-1772 (o) 425-453-0603 (f) DrFerris@lkwv.com Current Positions: Member & Partner, Lake Washington Vascular PLLC 2003-present Medical Director, Lake Washington Vascular Laboratory (ICAVL certified) Chief of Surgery, Overlake Hospital Medical Center 2012-present Investigator: Varisolve Cinical Trial Investigator: Rensonate Clinical Trial Investigator: Recover II Clinical Trial Regional Symposium Speaker: Cryovascular Technologies, Boston Scientific, 2004-2005 Instructor: Post-Graduate Training: Endovascular Technologies, Overlake Hospital Medical Center, 2004-2006. Cardiovascular Sterring Committee, Evergreen Hospital Medical Center 2007-2008. Committee Member, Peer Review, Overlake Hospital Medical Center, 2006-2008 Hospital and Surgical Center Privileges Overlake Hospital Medical Center, Bellevue, Washington: Endovascular, Vascular Surgery. 2003-present. Evergreen Hospital Medical Center, Kirkland, Washington: Endovascular and Vascular Surgery. 2003-present. Swedish Hospital, Seattle, Washington: Endovascular and Vascular Surgery (Courtesy). 2003-present. Overlake Surgical Center. 2003-present. Evergreen Surgical Center. 2003-present
Professional Licensure Washington licensure, January 2003 Oregon licensure,17 July, 1998. United States National Licensure Examinations, Part I, 1993; Part II, 1995. Part III, 1996. Post-Graduate Training Board Certified Vascular Surgeon, 18 May 2004. Board Certified General Surgeon, 4 June 2002. Vascular Surgery Fellow, Section of Vascular Surgery, Department of Surgery, University of Arizona Medical Center. 1 July 2001 through 30 June 2003. General Surgery Residency, Oregon Health Sciences University, Portland, Oregon 1 July, 1996 through 30 June, 2001. General Surgery Internship, Oregon Health Sciences University, Portland, Oregon 26 June, 1995 through 25 June, 1996. Education University of Virginia, School of Medicine; Charlottesville, Virginia Doctor of Medicine, May 1995 Attendance 1991-1995 College of William and Mary; Williamsburg, Virginia Bachelor of Science in Chemistry, Cum Laude, May 1991 Attendance 1987-1995 Honors and Awards College of William and Mary High Honors, Senior Thesis, Chemistry Dean s List Alpha Lambda Delta, Academic Honor Society, Liberal Arts Phi Eta Sigma, Academic Honor Society, Liberal Arts
Gamma Sigma Epsilon, Academic Honor Society, Chemistry American Chemistry Society Recognition Boy Scouts of America Eagle Scout Clinical Interest Advanced Endovascular Techniques. Peripheral, infrainguinal intervention. Carotid Stent, Thoracic endograft. Endovenous ablation Non-invasive Vascular Examination Research Varisolve: Phase III Randomized, Blinded, Multicenter Study to Evaluate Efficacy and Safety of Varisolve Poli docanol Endovenous Microfoam 0.5%, 1.0% and 2.0% Compared to Vehicle for the Treatment of Saphenofemoral Junction Incompetence. Revise Study: Phase III Gore Viabahn Endoprosthesis verse Percutaneous Transluminal Angioplasty (PTA) to Revise Arteriovenous Grafts at the Venous Anastomosis in Hemodialysis Patients Varisolve: An Open_label, Single Dose Pilot Study to Ealuate the Efficacy and Safety of Varisolve (polidocanol endovenous microfoam) ).125% [0.2%] for the Treatment of Symptomatic, Visible Varicose Veins with Saphenofemoral Incompetence Recover II: A Phase III Randomised, Double Blind, Parallel-Group Study of the Efficacy and Safety of Oral Dabigatran Etexilate (150mg BID) compared to Warfarin (INR 2-3) for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism, Following initial Treatment for Atleast 5 days with a Parenteral Antocoagulant Approved for this Indication Resonante: Twice Daily Oral Direct Thrombin InhibitorDabigatran Etexilate in the Long-Term Prevention of Recurrent Symptomatic Venous
Thromboembolism in Patients with Symptmatic Deep-Vein Thrombosis or Pulmonary Embolism Open Label, Multi-center Safety Study of the Varisolve Procedure for Treatment of Varicose Vein with Right to Left Cardiac Shunt Post Graduate, University of Arizona Utility of Early Post-operative Duplex Surveillance for Lower Extremity Bypass. Determination of Confidence Intervals and Diurnal Variation of Non-Invasive Assessment of Chronic Venous Insufficiency. Post Graduate, Oregon Health Sciences University Etiology of Hypothenar Hammer Syndrome: Fibromuscular Dysplasia. Determination of Confidence Intervals and Diurnal Variation of Non-Invasive Assessment of Chronic Venous Insufficiency. Diagnosis and Clinical Course of Raynaud s Syndrome, co-investigator Safety and efficacy of Propionyl L-Carnitine in peripheral arterial disease (intermittent claudication) as assessed by a graded treadmill protocol in a responder patient population, co-investigator,industry sponsored. A TwentyFour Week, Randomized, DoubleBlind Study of the Effects of Pletal (cilostazol) versus Trental (pentoxifylline) and Placebo Administered Orally to Patients with Intermittent Claudication Secondary to Peripheral Arterial Disease, co-investigator, industry sponsored. A 1-Year Randomized, Double-Blind Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy of Avasimibe in Patients With Peripheral Arterial Disease, co-investigator, industry sponsored. Homocysteine and Progression of Atherosclerosis, co-investigator. Magnetic Resonance Angiography in the Preoperative Evaluation for Hemodialysis Access.
Relationships Between Operative Approaches and Outcomes in Esophageal Cancer. Digital Hypothermic Challenge Testing for Confirmation of Raynaud s Syndrome Secondary to the Vibrating Pneumatic Air Knife. A Randomized, Double Blinded Placebo-Controlled Dose Response, Efficacy and Safety Study of Iloprost Clathrate Extended-Release Capsules in Patients with Peripheral Arterial Occlusive Disease (Fontaine Stage II), Co-investigator, industry sponsored. Isolated Perfused Pancreas/Pancreas and Liver to Examine Insulin Secretion Patterns After Immunosuppression in a Rat Model. Presentations Internal Iliac Artery Occlusive Disease, Case Study. Pacific Northwest Endovascular Symposium, Maadigan Hospital, March 2008. Overlake Nurse Symposium. Venous Thromboembolism, 2007. Overlake, Grand Rounds. Abdominal Aortic Aneurysm, 2005. Evergreen, Grand Rounds. Abodminal Aortic Aneurysm, 2004. Evergreen, Grand Rounds. Carotid Artery Occlusive Disease, 2006. Post-Graduate Seminar: Endovascular Skills, Overlake Hospital, quarterly 2004-2006. Overlake Vascular Symposium, September 2004. The Etiology of Hypothenar Hammer Syndrome: Fibromuscular Dysplasia. Society for Vascular Surgery, 53rd Annual Meeting, Washington, DC, 6-9 June 1999. The Etiology of Hypothenar Hammer Syndrome: Fibromuscular Dysplasia, Western Vascular Society, Resident Forum, September 1999, Lake Tahoe, CA. The Etiology of Hypothenar Hammer Syndrome: Fibromuscular Dysplasia, Portland Vascular Society; March 1999, Portland, OR
Pulmonary Embolus, Deep Vein Thrombosis, and Venous Disease. Medical Student Lecture Series, Winter 1998, Oregon Health Sciences University. Peripheral Arterial Occlusive Disease. Medical Student Lecture Series, Winter 1998, Oregon Health Sciences University. Magnetic Resonance Angiography in the Preoperative Evaluation for Hemodialysis Access, ACCESS Conference; May 1998, Miami, FL Relationships Between Operative Approaches and Outcomes in Esophageal Cancer, North Pacific Surgical; September 1997, Portland, OR Management of Colorectal Foreign Bodies, Northwest Colorectal Society. September 1997, Sun Valley, ID Publications Endovenous Laser Treatment of the Short Saphenous Vein: Efficacy and Complications, Journal of Vascular surgery 2007;45(4):795-803. Treatment of Chronic Visceral Ischemia, American College of Surgeons postgraduate course in vascular surgery, 1999. Carotid Screening Before Aortic Surgery, for Handbook of Aortic Surgery, 1999. Duplex Scanning and Spectral Analysis of Carotid Artery Occlusive Disease: Improving Relevance to Clinical Practice, for Advances in Vascular Surgery, volume 7, 1999. Magnetic Resonance Angiography in the Preoperative Evaluation for Hemodialysis Access, for Access, 1998. Relationships Between Operative Approaches and Outcomes in Esophageal Cancer. American Journal of Surgery 1998;175(5):422-5. Duplex Scanning and Spectral Analysis of Carotid Artery Occlusive Disease, 1998. for Current Therapy in Vascular Surgery, 4th ed, 1998. Surgical Endocrinology, for Advanced Surgical Recall, 1st ed, 1997. Adaptive Air Travel Transportation Systems for Persons with Disabilities. Journal of Burn Care & Rehabilitation 1994;15(5):441-6.
Professional Society Membership Peripheral Vascular Society Pacific Northwest Vascular Society Washington State Medical Society American College of Surgeons American Medical Association. Oregon Medical Association. Leadership Positions Peer Review, Overlake Hospital, 2005-present Oregon Health Sciences University Residency Committee, 1998 Assistant, Medical Student Gross Anatomy Lab, 1997-98. University of Virginia Operation Smile, Co-founder of medical school chapter. Liaison to local community chapter, 1993 to 1995. College of William and Mary Chemistry Society, Treasurer, 1990-1991. Experiences and Activities Oregon Health Sciences University Assistant, Medical Student Gross Anatomy Laboratory, 1997-98 Advanced Trauma Life Support, certified provider Advanced Cardiac Life-Support, certified provider Basic Life Support, certified provider University of Virginia Operation Smile International International Work/Education Exchange, Czechoslovakia; Summer, 1992 Volunteer, Free Clinic, Charlottesville and Lynchburg, Virginia; 1994 Teaching Assistant, Surgical Techniques Lab, 1995 Medical Student Society, Organ Donation Awareness Living Will/Power of Attorney Awareness Undergraduate student orientation, Drug/Sexual Abuse Awareness Delegate, AMA and Virginia Medical Society College of William and Mary Volunteer, Williamsburg Community Hospital, Physical Therapy Volunteer, Housing Partnerships Teaching Assistant, Organic and Inorganic Chemistry Labs Honor Council Chemistry Society